Phadia develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
February 24, 2010
CAPture: Issue No. 1, 2010
Read more »
February 9, 2010
Press release Europe: Phadia brings the first and only point of care in vitro specific IgE allergy test into the physician’s office with final FDA clearance of the ImmunoCAP® Rapid System
January 26, 2010
Press Release US: Phadia Brings the First and Only Point of Care In Vitro Specific IgE Allergy Test Into the Physician’s Office with Final FDA Clearance of the ImmunoCAP® Rapid System